UOC
PARN

UBS O'Connor’s Parnell Pharmaceuticals Holdings Ltd PARN Stock Holding History

UBS O'Connor’s Portfolio PARN Stock Details PARN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-78,681
Closed -$386K – 1015
2015
Q1 		$386K Sell
78,681
-44,219
-36% -$204K 0.01% 560
2014
Q4 		$509K Sell
122,900
-17,200
-12% -$78.1K 0.01% 413
2014
Q3 		$806K Buy
+140,100
New +$844K 0.01% 363

Other funds holding PARN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS O'Connor's PARN Position: Q2 2015 in Review

UBS O'Connor sold out of Parnell Pharmaceuticals Holdings Ltd (PARN) in Q2 2015, closing a stake of 78,681 shares — an estimated $386K sold.

UBS O'Connor first reported a position in PARN in Q3 2014 and held it in 3 quarters. The position peaked at $806K in Q3 2014. 14 funds tracked by Wall St. Rank hold PARN as of Q2 2015.

  • UBS O'Connor reported no remaining Parnell Pharmaceuticals Holdings Ltd position as of Q2 2015 after selling out during the quarter.
  • UBS O'Connor sold 78,681 Parnell Pharmaceuticals Holdings Ltd shares in Q2 2015, an estimated $386K.
  • UBS O'Connor first reported a position in Parnell Pharmaceuticals Holdings Ltd in Q3 2014 and held it in 3 quarters.
  • UBS O'Connor's Parnell Pharmaceuticals Holdings Ltd position peaked at $806K in Q3 2014.
  • 14 funds tracked by Wall St. Rank held Parnell Pharmaceuticals Holdings Ltd as of Q2 2015.

Based on UBS O'Connor's 13F filing for Q2 2015, filed 13 Aug 2015.